Cargando…
External Validation of the KOOS-ACL in the MOON Group Cohort of Young Athletes Followed for 10 Postoperative Years
BACKGROUND: The Knee injury and Osteoarthritis Outcome Score–Anterior Cruciate Ligament (KOOS-ACL) is a short form version of the KOOS, developed to target populations of young active patients with ACL tears. The KOOS-ACL consists of 2 subscales: Function (8 items) and Sport (4 items). The KOOS-ACL...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155281/ https://www.ncbi.nlm.nih.gov/pubmed/37026768 http://dx.doi.org/10.1177/03635465231160726 |
_version_ | 1785036296634236928 |
---|---|
author | Marmura, Hana Tremblay, Paul F. Bryant, Dianne M. Spindler, Kurt P. Huston, Laura J. Getgood, Alan M.J. |
author_facet | Marmura, Hana Tremblay, Paul F. Bryant, Dianne M. Spindler, Kurt P. Huston, Laura J. Getgood, Alan M.J. |
author_sort | Marmura, Hana |
collection | PubMed |
description | BACKGROUND: The Knee injury and Osteoarthritis Outcome Score–Anterior Cruciate Ligament (KOOS-ACL) is a short form version of the KOOS, developed to target populations of young active patients with ACL tears. The KOOS-ACL consists of 2 subscales: Function (8 items) and Sport (4 items). The KOOS-ACL was developed and validated using data from the Stability 1 study from baseline to postoperative 2 years. PURPOSE: To validate the KOOS-ACL in an external sample of patients matching the outcome’s target population. STUDY DESIGN: Cohort study (diagnosis); Level of evidence, 1. METHODS: The Multicenter Orthopaedic Outcomes Network group cohort of 839 patients aged 14 to 22 years who tore their ACLs while playing sports was used to assess internal consistency reliability, structural validity, convergent validity, responsiveness to change, and floor/ceiling effects of the KOOS-ACL at 4 time points: baseline and postoperative 2, 6, and 10 years. Detection of treatment effects between graft type (hamstring tendon vs bone–patellar tendon–bone) were also compared between the full-length KOOS and KOOS-ACL. RESULTS: The KOOS-ACL demonstrated acceptable internal consistency reliability (α = .82-.89), structural validity (Tucker-Lewis index and comparative fit index = 0.98-0.99; standardized root mean square residual and root mean square error of approximation = 0.04-0.07), convergent validity (Spearman correlation with International Knee Documentation Committee subjective knee form = 0.66-0.85; Western Ontario and McMaster Universities Osteoarthritis Index function = 0.84-0.95), and responsiveness to change across time (large effect sizes from baseline to postoperative 2 years; d = 0.94 [Function] and d = 1.54 [Sport]). Stable scores and significant ceiling effects were seen from 2 to 10 years. No significant differences in KOOS or KOOS-ACL scores were detected between patients with different graft types. CONCLUSION: The KOOS-ACL shows improved structural validity when compared with the full-length KOOS and adequate psychometric properties in a large external sample of high school and college athletes. This strengthens the argument to use the KOOS-ACL to assess young active patients with ACL tears in clinical research and practice. |
format | Online Article Text |
id | pubmed-10155281 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-101552812023-05-04 External Validation of the KOOS-ACL in the MOON Group Cohort of Young Athletes Followed for 10 Postoperative Years Marmura, Hana Tremblay, Paul F. Bryant, Dianne M. Spindler, Kurt P. Huston, Laura J. Getgood, Alan M.J. Am J Sports Med Articles BACKGROUND: The Knee injury and Osteoarthritis Outcome Score–Anterior Cruciate Ligament (KOOS-ACL) is a short form version of the KOOS, developed to target populations of young active patients with ACL tears. The KOOS-ACL consists of 2 subscales: Function (8 items) and Sport (4 items). The KOOS-ACL was developed and validated using data from the Stability 1 study from baseline to postoperative 2 years. PURPOSE: To validate the KOOS-ACL in an external sample of patients matching the outcome’s target population. STUDY DESIGN: Cohort study (diagnosis); Level of evidence, 1. METHODS: The Multicenter Orthopaedic Outcomes Network group cohort of 839 patients aged 14 to 22 years who tore their ACLs while playing sports was used to assess internal consistency reliability, structural validity, convergent validity, responsiveness to change, and floor/ceiling effects of the KOOS-ACL at 4 time points: baseline and postoperative 2, 6, and 10 years. Detection of treatment effects between graft type (hamstring tendon vs bone–patellar tendon–bone) were also compared between the full-length KOOS and KOOS-ACL. RESULTS: The KOOS-ACL demonstrated acceptable internal consistency reliability (α = .82-.89), structural validity (Tucker-Lewis index and comparative fit index = 0.98-0.99; standardized root mean square residual and root mean square error of approximation = 0.04-0.07), convergent validity (Spearman correlation with International Knee Documentation Committee subjective knee form = 0.66-0.85; Western Ontario and McMaster Universities Osteoarthritis Index function = 0.84-0.95), and responsiveness to change across time (large effect sizes from baseline to postoperative 2 years; d = 0.94 [Function] and d = 1.54 [Sport]). Stable scores and significant ceiling effects were seen from 2 to 10 years. No significant differences in KOOS or KOOS-ACL scores were detected between patients with different graft types. CONCLUSION: The KOOS-ACL shows improved structural validity when compared with the full-length KOOS and adequate psychometric properties in a large external sample of high school and college athletes. This strengthens the argument to use the KOOS-ACL to assess young active patients with ACL tears in clinical research and practice. SAGE Publications 2023-04-07 2023-05 /pmc/articles/PMC10155281/ /pubmed/37026768 http://dx.doi.org/10.1177/03635465231160726 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Articles Marmura, Hana Tremblay, Paul F. Bryant, Dianne M. Spindler, Kurt P. Huston, Laura J. Getgood, Alan M.J. External Validation of the KOOS-ACL in the MOON Group Cohort of Young Athletes Followed for 10 Postoperative Years |
title | External Validation of the KOOS-ACL in the MOON Group Cohort of Young Athletes Followed for 10 Postoperative Years |
title_full | External Validation of the KOOS-ACL in the MOON Group Cohort of Young Athletes Followed for 10 Postoperative Years |
title_fullStr | External Validation of the KOOS-ACL in the MOON Group Cohort of Young Athletes Followed for 10 Postoperative Years |
title_full_unstemmed | External Validation of the KOOS-ACL in the MOON Group Cohort of Young Athletes Followed for 10 Postoperative Years |
title_short | External Validation of the KOOS-ACL in the MOON Group Cohort of Young Athletes Followed for 10 Postoperative Years |
title_sort | external validation of the koos-acl in the moon group cohort of young athletes followed for 10 postoperative years |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155281/ https://www.ncbi.nlm.nih.gov/pubmed/37026768 http://dx.doi.org/10.1177/03635465231160726 |
work_keys_str_mv | AT marmurahana externalvalidationofthekoosaclinthemoongroupcohortofyoungathletesfollowedfor10postoperativeyears AT tremblaypaulf externalvalidationofthekoosaclinthemoongroupcohortofyoungathletesfollowedfor10postoperativeyears AT bryantdiannem externalvalidationofthekoosaclinthemoongroupcohortofyoungathletesfollowedfor10postoperativeyears AT spindlerkurtp externalvalidationofthekoosaclinthemoongroupcohortofyoungathletesfollowedfor10postoperativeyears AT hustonlauraj externalvalidationofthekoosaclinthemoongroupcohortofyoungathletesfollowedfor10postoperativeyears AT getgoodalanmj externalvalidationofthekoosaclinthemoongroupcohortofyoungathletesfollowedfor10postoperativeyears |